NCT05327894
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05327894 |
| Title | Interfant-21 Treatment Protocol for Infants Under 1 Year with KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia (Interfant-21) |
| Acronym | Interfant-21 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Princess Maxima Center for Pediatric Oncology |
| Indications | |
| Therapies | |
| Age Groups: | child |
| Covered Countries | SWE | SVK | NOR | NLD | LTU | ITA | IRL | HUN | GRC | FRA | FIN | ESP | DNK | DEU | CZE | BEL | AUT | AUS | ARG |
CKB BOOST